about
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer.Use of the Prostate Core Mitomic Test in Repeated Biopsy Decision-Making: Real-World Assessment of Clinical Utility in a Multicenter Patient PopulationMetabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cellsCellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipinEvolution of Tumor Metabolism might Reflect Carcinogenesis as a Reverse Evolution process (Dismantling of Multicellularity).Association of leukocyte mitochondrial DNA copy number with colorectal cancer risk: Results from the Shanghai Women's Health Study.Tumor metabolism, cancer cell transporters, and microenvironmental resistance.Simultaneous quantitative assessment of circulating cell-free mitochondrial and nuclear DNA by multiplex real-time PCR.Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey.Review: mitochondrial defects in breast cancerGenetic insights into OXPHOS defect and its role in cancerSimultaneous quantification of mitochondrial DNA copy number and deletion ratio: a multiplex real-time PCR assay.Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53Effects of high adherence to mediterranean or low-fat diets in medicated secondary prevention patientsLevels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.Mitochondrial DNA mutations and breast tumorigenesis.Mitochondrial DNA depletion sensitizes cancer cells to PARP inhibitors by translational and post-translational repression of BRCA2.Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer.Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.Deletion of a novel F-box protein, MUS-10, in Neurospora crassa leads to altered mitochondrial morphology, instability of mtDNA and senescence.D-loop somatic mutations and ∼5 kb "common" deletion in mitochondrial DNA: important molecular markers to distinguish oral precancer and cancer.Mitochondrial DNA in Lung Cancer.
P2860
Q33520078-C4931E73-0A3A-4EE7-B32A-7EE7F19BBDEDQ33572829-25B592A7-ED78-47BE-9B8C-D0A5971989DEQ33895232-36337540-3E18-4CDC-9922-35D30AD7B575Q34026273-5FE4FD2D-7345-45B9-BF97-D2297488578DQ34390032-E6FF0C47-621E-45A6-B58E-F3CD1AA8F857Q34459104-95C5E4BE-EA0E-4425-A1F3-2056A980990FQ34513382-0925DD2E-F602-4455-B526-6A02A413FCE6Q34548398-A0512238-B07F-41F0-A575-209B6A221212Q34785931-7EE4522F-1A0F-4293-A5AB-FAAA557AEF44Q35181094-96212EAF-B8D5-4688-95FE-85F27A7CE57EQ36377723-DEE7A638-1E74-4ADE-B6F9-8690E2B327A2Q36972506-308B254B-C099-4DB6-8607-875BD9356926Q37077431-027C841E-E9A2-4301-A654-85197FC34252Q37323148-8C88CC7F-07B8-464E-AD8B-4A0773977A05Q37429524-003E4019-8432-4E6D-82E6-F4C02CFDD803Q37477802-B97ED9C9-61E3-4AA7-9933-3CFA0F0E031BQ37614527-E23FB721-6742-4E60-9B3D-AB442E504CC2Q37731334-9DBA67CB-40C7-40C3-B0F6-93E0E92B68A5Q39905594-AC8CCB9D-B27A-4B91-BBCE-19844A6D26C0Q42066248-32BC7FC7-D766-4120-BD51-9AC3ABCE09D7Q46796420-EA08B6BD-68AE-41C8-B521-09B83590F319Q49605186-8664811D-E082-47E1-A521-7942F222C1B5
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Regulation of mitochondrial DNA content and cancer.
@ast
Regulation of mitochondrial DNA content and cancer.
@en
type
label
Regulation of mitochondrial DNA content and cancer.
@ast
Regulation of mitochondrial DNA content and cancer.
@en
prefLabel
Regulation of mitochondrial DNA content and cancer.
@ast
Regulation of mitochondrial DNA content and cancer.
@en
P2860
P1433
P1476
Regulation of mitochondrial DNA content and cancer.
@en
P2093
Masahiro Higuchi
P2860
P356
10.1016/J.MITO.2006.12.001
P577
2006-12-05T00:00:00Z